Skip to main content
Top
Published in: Drugs & Aging 9/2012

01-09-2012 | Original Research Article

Comparison of Prescription Drug Use between Community-Dwelling and Institutionalized Elderly in Sweden

Authors: Kristina Johnell, Johan Fastbom

Published in: Drugs & Aging | Issue 9/2012

Login to get access

Abstract

Background

Most previous studies about drug use in the elderly population have either investigated drug use in institutions or in the community-dwelling setting. Hence, very few studies have compared drug use in institutionalized and community-dwelling elderly, maybe because of a lack of sufficiently large databases.

Objective

The aim of the study was to investigate differences in drug use patterns between community-dwelling and institutionalized elderly, after adjustment for age, gender and number of other drugs (used as a proxy for overall co-morbidity).

Methods

We analysed data from individuals aged ≥65 years who filled at least one drug prescription between July and September 2008 and were consequently registered in the Swedish Prescribed Drug Register (n = 1,347,564; 1,260,843 community-dwelling and 86,721 institutionalized elderly). A list of current prescriptions was constructed for every individual on the arbitrarily chosen date 30 September 2008. Outcome measures were the 20 most common drug classes and the 20 most common individual drugs. Logistic regression analysis was used to investigate whether institutionalization was associated with use of these drugs, after adjustment for age, gender and number of other drugs.

Results

Institutionalized elderly were more likely than community-dwelling elderly to use antidepressants, laxatives, minor analgesics, opioids and hypnotics/sedatives, after adjustment for age, gender and number of other drugs. On the contrary, institutionalization was negatively associated with use of lipid modifying agents, angiotensin II antagonists, selective calcium channel blockers, β-blocking agents and ACE inhibitors, after adjustment for age, gender and number of other drugs.

Conclusions

Our results indicate that institutionalized elderly are more likely than community-dwelling elderly to use psychotropics, analgesics and laxatives, but less likely to receive recommended cardiovascular drug therapy, which may indicate a need for implementation of evidence-based guidelines for drug treatment in this vulnerable group of elderly patients. Further research is needed to elucidate to what extent the differences in drug use between community-dwelling and institutionalized elderly are explained by different underlying disease patterns and by different prescribing traditions in the different settings.
Literature
1.
go back to reference Haider SI, Johnell K, Johnell K, Ringbäck Weitoft G, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57:62–9.PubMedCrossRef Haider SI, Johnell K, Johnell K, Ringbäck Weitoft G, et al. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people. J Am Geriatr Soc. 2009;57:62–9.PubMedCrossRef
2.
go back to reference Jyrkkä J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151–8.PubMedCrossRef Jyrkkä J, Vartiainen L, Hartikainen S, et al. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ Study. Eur J Clin Pharmacol. 2006;62:151–8.PubMedCrossRef
3.
go back to reference Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf. 2011;20:488–96.PubMedCrossRef Nobili A, Franchi C, Pasina L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf. 2011;20:488–96.PubMedCrossRef
4.
go back to reference Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.PubMedCrossRef Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345–51.PubMedCrossRef
5.
go back to reference Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64:183–99.PubMedCrossRef Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64:183–99.PubMedCrossRef
6.
go back to reference Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care. 2007;25:9–14.PubMedCrossRef Bergman A, Olsson J, Carlsten A, et al. Evaluation of the quality of drug therapy among elderly patients in nursing homes. Scand J Prim Health Care. 2007;25:9–14.PubMedCrossRef
7.
go back to reference Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962–8.PubMedCrossRef Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962–8.PubMedCrossRef
8.
go back to reference Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc. 2004;52:861–6.PubMedCrossRef Lane CJ, Bronskill SE, Sykora K, et al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Geriatr Soc. 2004;52:861–6.PubMedCrossRef
9.
go back to reference Miles RW. Cognitive bias and planning error: nullification of evidence-based medicine in the nursing home. J Am Med Dir Assoc. 2010;11:194–203.PubMedCrossRef Miles RW. Cognitive bias and planning error: nullification of evidence-based medicine in the nursing home. J Am Med Dir Assoc. 2010;11:194–203.PubMedCrossRef
10.
go back to reference Furu K, Wettermark B, Andersen M, et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106:86–94.PubMedCrossRef Furu K, Wettermark B, Andersen M, et al. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106:86–94.PubMedCrossRef
11.
go back to reference Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619–25.PubMedCrossRef Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997;50:619–25.PubMedCrossRef
12.
go back to reference Johnell K, Fastbom J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people. Eur J Clin Pharmacol. 2011;67:1069–75.PubMedCrossRef Johnell K, Fastbom J. Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people. Eur J Clin Pharmacol. 2011;67:1069–75.PubMedCrossRef
13.
go back to reference The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD). Oslo: WHO Collaborating Centre for Drug Statistics Methodology [online]. Available from URL: http://www.whocc.no/ [Accessed 2012 Feb 1]. The Anatomical Therapeutic Chemical (ATC) classification system and the Defined Daily Dose (DDD). Oslo: WHO Collaborating Centre for Drug Statistics Methodology [online]. Available from URL: http://​www.​whocc.​no/​ [Accessed 2012 Feb 1].
14.
go back to reference Johnell K, Fastbom J, Rosen M, et al. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother. 2007;41:1243–8.PubMedCrossRef Johnell K, Fastbom J, Rosen M, et al. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother. 2007;41:1243–8.PubMedCrossRef
16.
go back to reference Nordberg G, Wimo A, Jonsson L, et al. Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project—a population based study in Sweden. Int J Geriatr Psychiatry. 2007;22:639–48.PubMedCrossRef Nordberg G, Wimo A, Jonsson L, et al. Time use and costs of institutionalised elderly persons with or without dementia: results from the Nordanstig cohort in the Kungsholmen Project—a population based study in Sweden. Int J Geriatr Psychiatry. 2007;22:639–48.PubMedCrossRef
17.
go back to reference Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854–64.PubMedCrossRef Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154:854–64.PubMedCrossRef
18.
go back to reference Giron MS, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Invest. 1999;17:389–98.CrossRef Giron MS, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Invest. 1999;17:389–98.CrossRef
19.
go back to reference Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry. 2001;16:900–6.PubMedCrossRef Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry. 2001;16:900–6.PubMedCrossRef
20.
go back to reference Hosia-Randell H, Pitkala K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22:793–800.PubMedCrossRef Hosia-Randell H, Pitkala K. Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging. 2005;22:793–800.PubMedCrossRef
21.
go back to reference Richter T, Mann E, Meyer G, et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc. 2012;13(187):e7–13.PubMed Richter T, Mann E, Meyer G, et al. Prevalence of psychotropic medication use among German and Austrian nursing home residents: a comparison of 3 cohorts. J Am Med Dir Assoc. 2012;13(187):e7–13.PubMed
22.
go back to reference Lesen E, Carlsten A, Skoog I, et al. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. Int Psychogeriatr. 2011;23:1270–7.PubMedCrossRef Lesen E, Carlsten A, Skoog I, et al. Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. Int Psychogeriatr. 2011;23:1270–7.PubMedCrossRef
23.
go back to reference Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc. 2001;49:1673–8.PubMedCrossRef Svarstad BL, Mount JK. Chronic benzodiazepine use in nursing homes: effects of federal guidelines, resident mix, and nurse staffing. J Am Geriatr Soc. 2001;49:1673–8.PubMedCrossRef
24.
go back to reference Sonntag A, Matschinger H, Angermeyer MC, et al. Does the context matter? Utilization of sedative drugs in nursing homes—a multilevel analysis. Pharmacopsychiatry. 2006;39:142–9.PubMedCrossRef Sonntag A, Matschinger H, Angermeyer MC, et al. Does the context matter? Utilization of sedative drugs in nursing homes—a multilevel analysis. Pharmacopsychiatry. 2006;39:142–9.PubMedCrossRef
25.
go back to reference Haasum Y, Fastbom J, Fratiglioni L, et al. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28:283–93.PubMedCrossRef Haasum Y, Fastbom J, Fratiglioni L, et al. Pain treatment in elderly persons with and without dementia: a population-based study of institutionalized and home-dwelling elderly. Drugs Aging. 2011;28:283–93.PubMedCrossRef
26.
go back to reference Gibson SJ. IASP global year against pain in older persons: highlighting the current status and future perspectives in geriatric pain. Expert Rev Neurother. 2007;7:627–35.PubMedCrossRef Gibson SJ. IASP global year against pain in older persons: highlighting the current status and future perspectives in geriatric pain. Expert Rev Neurother. 2007;7:627–35.PubMedCrossRef
27.
go back to reference Hosia-Randell H, Suominen M, Muurinen S, et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging. 2007;24:147–54.PubMedCrossRef Hosia-Randell H, Suominen M, Muurinen S, et al. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging. 2007;24:147–54.PubMedCrossRef
28.
go back to reference Levy CR, Radcliff TA, Williams ET, et al. Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc. 2009;10:56–61.PubMedCrossRef Levy CR, Radcliff TA, Williams ET, et al. Acute myocardial infarction in nursing home residents: adherence to treatment guidelines reduces mortality, but why is adherence so low? J Am Med Dir Assoc. 2009;10:56–61.PubMedCrossRef
29.
go back to reference Allen LA, Hernandez AF, Peterson ED, et al. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011;4:293–300.PubMedCrossRef Allen LA, Hernandez AF, Peterson ED, et al. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail. 2011;4:293–300.PubMedCrossRef
30.
go back to reference Richardson DM, Bain KT, Diamond JJ, et al. Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis. Drugs Aging. 2010;27:845–54.PubMedCrossRef Richardson DM, Bain KT, Diamond JJ, et al. Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: a retrospective, survey-weighted, cohort analysis. Drugs Aging. 2010;27:845–54.PubMedCrossRef
31.
go back to reference Aronow WS, Rich MW, Goodlin SJ, et al. In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure. J Am Med Dir Assoc. 2012;13:448–52.PubMedCrossRef Aronow WS, Rich MW, Goodlin SJ, et al. In-hospital cardiology consultation and evidence-based care for nursing home residents with heart failure. J Am Med Dir Assoc. 2012;13:448–52.PubMedCrossRef
32.
go back to reference Lapane KL, Spooner JJ, Mucha L, et al. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc. 2001;49:577–84.PubMedCrossRef Lapane KL, Spooner JJ, Mucha L, et al. Effect of nonsteroidal anti-inflammatory drug use on the rate of gastrointestinal hospitalizations among people living in long-term care. J Am Geriatr Soc. 2001;49:577–84.PubMedCrossRef
33.
go back to reference Glew CM, Rentler RJ. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc. 2007;8:607–9.PubMedCrossRef Glew CM, Rentler RJ. Use of proton pump inhibitors and other acid suppressive medications in newly admitted nursing facility patients. J Am Med Dir Assoc. 2007;8:607–9.PubMedCrossRef
34.
go back to reference Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:546S–92S.PubMedCrossRef Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133:546S–92S.PubMedCrossRef
35.
go back to reference Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians’ reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther. 2003;25:1750–64.PubMedCrossRef Gross CP, Vogel EW, Dhond AJ, et al. Factors influencing physicians’ reported use of anticoagulation therapy in nonvalvular atrial fibrillation: a cross-sectional survey. Clin Ther. 2003;25:1750–64.PubMedCrossRef
Metadata
Title
Comparison of Prescription Drug Use between Community-Dwelling and Institutionalized Elderly in Sweden
Authors
Kristina Johnell
Johan Fastbom
Publication date
01-09-2012
Publisher
Springer International Publishing AG
Published in
Drugs & Aging / Issue 9/2012
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-012-0002-7

Other articles of this Issue 9/2012

Drugs & Aging 9/2012 Go to the issue

Adis Drug Profile

Tadalafil

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine